DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20193948

Next generation sequencing in early diagnosis of pneumocystis jirovecii pneumonia after chemotherapy: a case report

Donghua Zheng, Kai Chen, Fang Xiao, Na Liu

Abstract


The incidence of Pneumocystis pneumonia is increasing in immunosuppressive patients. How to diagnose and treat Pneumocystis pneumonia in the early stage has become an important issue for clinicians. The development of Next-generation Sequencing (NGS) provides technical support for the diagnosis of Pneumocystis pneumonia. Case report: A 14-year-old male patient was diagnosed with T lymphoblastoma and treated with chemotherapy. After chemotherapy, the patient developed bone marrow suppression and was complicated with severe pneumonia. He was given endotracheal intubation and ventilator assisted respiration. Samples of patients' alveolar lavage fluid were obtained, and Next-generation Sequencing (NGS) was used for diagnosis, confirming the pathogen as Pneumocystis jiroveci, which was treated by TMP/SMX. The patient's condition gradually improved, and was finally removed from ventilator and endotracheal tube. Pneumocystis jiroveci is a common opportunistic pathogen in immunosuppressive patients, and Next-generation Sequencing (NGS) can be used for rapid diagnosis of Pneumocystis pneumonia, thus improving the clinical therapeutic effect.

 


Keywords


Acute respiratory distress syndrome, Early diagnosis, Next-generation Sequencing, Patient in critical conditions, Pneumocystis jirovecii

Full Text:

PDF

References


Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev. 2012 Apr;25(2):297-317.

Duboucher C, Boggia R, Morel G, Capron M, Pierce RJ, Dei-Cas E, et al. Pneumocystis pneumonia: immunosuppression, Pneumocystis jirovecii. and the third man. Nat Rev Microbiol. 2007 Dec;5(12):967.

Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016 May 17;17(6):333-51.

Deurenberg RH, Bathoorn E, Chlebowicz MA, Couto N, Ferdous M, García-Cobos S, et al. Application of next generation sequencing in clinical microbiology and infection prevention. J Biotechnol. 2017 Feb 10;243:16-24.

Cawcutt K, De Moraes AG, Lee SJ, Park JG, Schears GJ, Nemergut ME. The use of ECMO in HIV/AIDS with Pneumocystis jirovecii Pneumonia: a case report and review of the literature. ASAIO J. 2014 Sep-Oct;60(5):606-8.

Papazian L, Calfee CS, Chiumello D, Luyt CE, Meyer NJ, Sekiguchi H, et al. Diagnostic workup for ARDS patients. Intensive care medicine. 2016 May 1;42(5):674-85.

Catherinot E, Lanternier F, Bougnoux ME, , Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am. 2010 Mar;24(1):107-38.

Herrag M, Elfassy Fihry MT, Alaoui Yazidi A. Pneumocystis jirovecii: what does this mean? Rev Pneumol Clin. 2010 Dec;66(6):342-6.

De Castro N, Scemla A, Gallien S. Pneumocystis jirovecii pneumonia in HIV-infected patients. Rev Mal Respir. 2012 Jun;29(6):793-802.

Rouyer M, Stoclin A, Blanc FX. Pneumocystis pneumonia in HIV-negative adults. Rev Mal Respir. 2015 Dec;32(10):985-90.

White PL, Backx M, Barnes RA. Diagnosis and management of Pneumocystis jirovecii infection. Expert Rev Anti Infect Ther. 2017 May;15(5):435-447.

Tasaka S, Tokuda H. Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults. Expert Opin Med Diagn. 2013 Jan;7(1):85-97.

Song Y, Ren Y, Wang X, Li R. Recent Advances in the Diagnosis of Pneumocystis Pneumonia. Med Mycol J. 2016;57(4):E111-6.

Chabé M, Durand-Joly I, Dei-Cas E. Transmission of Pneumocystis infection in humans. Med Sci (Paris). 2012 Jun-Jul;28(6-7):599-604.

Reid AB, Chen SC, Worth LJ. Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis. 2011 Dec;24(6):534-44.

Capobianchi MR, Giombini E, Rozera G. Next-generation sequencing technology in clinical virology. Clin Microbiol Infect. 2013 Jan;19(1):15-22.

Deurenberg RH, Bathoorn E, Chlebowicz MA, Couto N, Ferdous M, García-Cobos S, et al. Application of next generation sequencing in clinical microbiology and infection prevention. J Biotechnol. 2017 Feb 10;243:16-24.

Yi Zhang, Jing-Wen Ai, Peng Cui, Zhang WH, Wu HL, Ye MZ. A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach. J Infect. 2019 Feb;78(2):158-69.

Lecuit M, Eloit M. The diagnosis of infectious diseases by whole genome next generation sequencing: a new era is opening. Front Cell Infect Microbiol. 2014 Mar 6;4:25.

Lefterova MI, Suarez CJ, Banaei N, Pinsky BA. Next-Generation Sequencing for Infectious Disease Diagnosis and Management: A Report of the Association for Molecular Pathol. J Mol Diagn. 2015 Nov;17(6):623-34.

Rinker DC, Pitts RJ, Zwiebel LJ. Disease vectors in the era of next generation sequencing. Genome Biol. 2016 May 6;17(1):95.